China Regenerative Medicine International Limited (Stock Code: 8158) announced that the dispatch of a circular relating to its previously disclosed major transactions and breach of GEM Listing Rules will be delayed. The circular was initially scheduled for dispatch on or before 21 November 2025 and pertains to the Outstanding Payment Agreement, the Membership Transfer Agreements, and other related details.
The announcement specifies that additional time is needed to finalize information to be included in the circular. The company is therefore applying to the Stock Exchange for a waiver from strict compliance with the relevant GEM Listing Rules. It is currently expected that the dispatch date of the circular will be postponed to a date on or before 31 December 2025.